Antengene
Antengene Corporation Limited, headquartered in China, is a pioneering biopharmaceutical company focused on the development and commercialisation of innovative therapies for cancer treatment. Founded in 2017, Antengene has rapidly established itself in the oncology sector, with a strong emphasis on precision medicine and targeted therapies. The company operates primarily in Asia-Pacific regions, aiming to address unmet medical needs through its robust pipeline of novel drug candidates. Antengene's core products include a range of innovative therapies that leverage cutting-edge technology, setting them apart in a competitive market. With notable achievements in clinical trials and strategic partnerships, Antengene is positioned as a key player in the biopharmaceutical industry, committed to improving patient outcomes and advancing cancer care globally.
DitchCarbon Score
How does Antengene's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Antengene's score of 25 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Antengene's reported carbon emissions
In 2023, Antengene Corporation Limited reported total carbon emissions of approximately 1,169,980 kg CO2e. This figure includes 45,220 kg CO2e from Scope 1 emissions and 1,124,760 kg CO2e from Scope 2 emissions. The company has shown a reduction in total emissions from 2022, where emissions were about 1,613,260 kg CO2e, comprising 551,320 kg CO2e in Scope 1 and 1,061,940 kg CO2e in Scope 2. Over the past few years, Antengene's emissions have decreased significantly, with a total of approximately 994,380 kg CO2e in 2021 and 278,470 kg CO2e in 2020. This trend indicates a commitment to reducing their carbon footprint, although no specific reduction targets or initiatives have been documented in their climate strategy. Antengene has not disclosed any Scope 3 emissions data, which typically includes indirect emissions from the supply chain and product use. The absence of such data suggests a potential area for future improvement in their sustainability reporting. Overall, while Antengene has made strides in reducing its direct emissions, the lack of formal reduction targets or commitments highlights an opportunity for the company to enhance its climate strategy and align with industry standards for sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 27,080 | 00,000 | 000,000 | 00,000 |
| Scope 2 | 251,390 | 000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Antengene is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
